Contact
searchSearch
HMP Global

Volume 14 - Issue 3 - March 2017

Feature

Case Report
Revascularization of Chronic Venous Occlusion in the Setting of Post-Thrombotic Syndrome
03/16/2017
Vincent M. Figueredo, MD; Sean Janzer, MD; Jon C. George, MD, MBA; Deepakraj Gajanana, MD; Dennis Morris
Post-thrombotic syndrome is a complication that may follow deep vein thrombosis, and is associated with significant morbidity. There is growing interest in endovascular techniques to treat this complication. We present a related case.
Post-thrombotic syndrome is a complication that may follow deep vein thrombosis, and is associated with significant morbidity. There is growing interest in endovascular techniques to treat this complication. We present a related case.
Post-thrombotic syndrome is a...
03/16/2017
Vascular Disease Management
Case Report
Transradial Carotid Artery Stenting
03/16/2017
Peter A. Soukas, MD, FACC, FSCAI, FACP, RPVI
The author presents a case report of transradial carotid artery stenting (CAS), reviews the data, and offers a suggested CAS access algorithm.
The author presents a case report of transradial carotid artery stenting (CAS), reviews the data, and offers a suggested CAS access algorithm.
The author presents a case...
03/16/2017
Vascular Disease Management
Original Research
The Peripheral RegIstry of Endovascular Clinical OutcoMEs (The PRIME Registry): Interim Analysis of the First 328 Subjects with Critical Limb Ischemia
03/15/2017
Sara Finton, BSN; Carmen Heaney, BSN; Theresa McGoff, BSN; Larry J. Diaz-Sandoval, MD; Fadi Saab, MD, FACC, FSCAI; Robert E. Beasley, MD, FSCAI, FSIR; George L. Adams, MD, MHS, MBA, FACC, FSCAI; Jihad A. Mustapha, MD, FACC, FSCAI
Subjects with critical limb ischemia (CLI) have high 1-year amputation and mortality rates.The clinical profile and outcomes of CLI subjects were characterized using the PRIME registry and compared with previous literature to highlight the...
Subjects with critical limb ischemia (CLI) have high 1-year amputation and mortality rates.The clinical profile and outcomes of CLI subjects were characterized using the PRIME registry and compared with previous literature to highlight the...
Subjects with critical limb...
03/15/2017
Vascular Disease Management

Insights

Interview
A Novel Device to Prevent Neointimal Hyperplasia Restenosis: The DANCE and LIMBO Trials
03/15/2017
Jennifer Ford
VDM spoke with George Adams, MD, MHS, at the 43rd Annual VEITH Symposium regarding the ongoing DANCE and LIMBO trials.
VDM spoke with George Adams, MD, MHS, at the 43rd Annual VEITH Symposium regarding the ongoing DANCE and LIMBO trials.
VDM spoke with George Adams, MD,...
03/15/2017
Vascular Disease Management
Editor's Corner
Cyber-Attacks: Rising Threat to Healthcare
03/15/2017
Vinay Kumar, MD; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Information about medical records, patient demographics, and Social Security numbers is extremely valuable. Electronic medical record systems are particularly vulnerable to cyber-attacks.
Information about medical records, patient demographics, and Social Security numbers is extremely valuable. Electronic medical record systems are particularly vulnerable to cyber-attacks.
Information about medical...
03/15/2017
Vascular Disease Management

Column

Editor's Corner
Electronic Medical Records and the Potential for Cyber-Attacks
03/15/2017
Cyber-security is of great importance to all physicians, health-care providers, and patients, particularly in this era of mandated electronic medical records.
Cyber-security is of great importance to all physicians, health-care providers, and patients, particularly in this era of mandated electronic medical records.
Cyber-security is of great...
03/15/2017
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Aortic Lesions
Gore Announces FDA Approval and First Commercial Implant of Large-Diameter Thoracic Tapers
04/03/2025
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24,...
04/03/2025
Vascular Disease Management
VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest

March 2017 Volume 14 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use